Endothelial nitric oxide synthase polymorphisms are associated with hypertension and cardiovascular disease in renal transplantation (Nephrology (2008) 13, (348-355) DOI: 10.1111/j.1440-1797.2008.00925.x);Endothelial nitric oxide synthase polymorphisms are associated with hypertension and cardiovascular disease in renal transplantation

Nephrology

Volumn 13, Issue 4, 2008, Pages 348-355

  Bhandary, Uswanathan V ^a   Tse, Wai ^a   Yang, Bingmei ^a   Knowles, Mark R ^a   Demaine, Andrew G ^a,b  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Allograft; Cardiovascular; Endothelial; Hypertension; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; BASE PAIRING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; INTRON; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NOS3 GENE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RECIPIENT;

EID: 43449101833     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01043.x     Document Type: Erratum

References (41)

1. 1 Radomski MW, Palmer RM, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 1987 ; 148: 1482–9.
2. 2 Spiecker M, Peng HB, Liao JK. Inhibition of endothelial vascular cell adhesion molecule‐1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J. Biol. Chem. 1997 ; 272: 30969–74.
3. 3 Sarkar R, Gordon D, Stanley JC, Webb RC. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am. J. Physiol. 1997 ; 272 (4 Pt 2): H1810–18.
4. 4 Parenti A, Morbidelli L, Cui XL et al. Nitric oxide is an upstream signal of vascular endothelial growth factor‐induced extracellular signal‐regulated kinase1/2 activation in postcapillary endothelium. J. Biol. Chem. 1998 ; 273: 4220–26.
5. 5 Park SK, Lin HL, Murphy S. Nitric oxide regulates nitric oxide synthase‐2 gene expression by inhibiting NF‐kappaB binding to DNA. Biochem. J. 1997 ; 322: 609–13.
6. 6 Chiueh CC. Neuroprotective properties of nitric oxide. Ann. N. Y. Acad. Sci. 1999 ; 890: 301–11.
7. 7 Maxwell AJ. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 2002 ; 6: 101–24.
8. 8 Clancy RM, Leszczynska‐Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 1992 ; 90: 1116–21.
9. 9 Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am. J. Physiol. 1997 ; 272 (5 Pt 2): F561–78.
10. 10 Kawachi S, Hines IN, Laroux FS et al. Nitric oxide synthase and postischemic liver injury. Biochem. Biophys. Res. Commun. 2000 ; 276: 851–4.
11. 11 Marsden PA, Heng HH, Scherer SW et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 1993 ; 268: 17478–88.
12. 12 Nakayama M, Yasue H, Yoshimura M et al. T‐786→C mutation in the 5′‐flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999 ; 99: 2864–70.
13. 13 Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate versus glutamate at position 298. Proc. Natl. Acad. Sci. USA 2000 ; 97: 2832–5.
14. 14 Tsukada T, Yokoyama K, Arai T et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 1998 ; 245: 190–3.
15. 15 Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking‐dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 1996 ; 2: 41–5.
16. 16 Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 2000 ; 57: 405–13.
17. 17 Morita T, Ito H, Suehiro T et al. Effect of a polymorphism of endothelial nitric oxide synthase gene in Japanese patients with IgA nephropathy. Clin. Nephrol. 1999 ; 52: 203–9.
18. 18 Buraczynska M, Ksiazek P, Zaluska W, Nowicka T, Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end‐stage renal disease. Nephrol. Dial. Transplant. 2004 ; 19: 2302–6.
19. 19 Bellini MH, Figueira MN, Piccoli MF et al. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end‐stage renal disease. Nephrology (Carlton) 2007 ; 12: 289–93.
20. 20 Nagase S, Suzuki H, Wang Y et al. Association of ecNOS gene polymorphisms with end stage renal diseases. Mol. Cell Biochem. 2003 ; 244: 113–18.
21. 21 Uwabo J, Soma M, Nakayama T, Kanmatsuse K. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am. J. Hypertens. 1998 ; 11 (1 Pt 1): 125–8.
22. 22 Zintzaras E, Kitsios G, Stefanidis I. Endothelial NO synthase gene polymorphisms and hypertension: A meta‐analysis. Hypertension 2006 ; 48: 700–10.
23. 23 Hingorani AD, Liang CF, Fatibene J et al. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999 ; 100: 1515–20.
24. 24 Noiri E, Satoh H, Taguchi J et al. Association of eNOS Glu298Asp polymorphism with end‐stage renal disease. Hypertension 2002 ; 40: 535–40.
25. 25 Persu A, Stoenoiu MS, Messiaen T et al. Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum. Mol. Genet 2002 ; 11: 229–41.
26. 26 Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: Meta‐analysis of 26 studies involving 23028 subjects. Circulation 2004 ; 109: 1359–65.
27. 27 Asakimori Y, Yorioka N, Taniguchi Y et al. T (‐786)→C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron 2002 ; 91: 747–51.
28. 28 Briggs JD. Causes of death after renal transplantation. Nephrol. Dial. Transplant. 2001 ; 16: 1545–9.
29. 29 Schwenger V, Zeier M, Ritz E. Hypertension after renal transplantation. Curr. Hypertens. Rep. 2001 ; 3: 434–9.
30. 30 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 ; 16: 1215.
31. 31 Ito S. Nitric oxide in the kidney. Curr. Opin. Nephrol. Hypertens. 1995 ; 4: 23–30.
32. 32 Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin. Nephrol. 2004 ; 24: 354–65.
33. 33 Raman CS, Li H, Martasek P, Kral V, Masters BS, Poulos TL. Crystal structure of constitutive endothelial nitric oxide synthase: A paradigm for pterin function involving a novel metal center. Cell 1998 ; 95: 939–50.
34. 34 Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC. Acidic hydrolysis as a mechanism for the cleavage of the Glu (298)→Asp variant of human endothelial nitric‐oxide synthase. J. Biol. Chem. 2001 ; 276: 26674–9.
35. 35 Miyamoto Y, Saito Y, Nakayama M et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a −786T→C mutation associated with coronary spastic angina. Hum. Mol. Genet 2000 ; 9: 2629–37.
36. 36 Hohage H, Bruckner D, Arlt M, Buchholz B, Zidek W, Spieker C. Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients. Clin. Nephrol. 1996 ; 45: 342–4.
37. 37 Vaziri ND, Ni Z, Zhang YP, Ruzics EP, Maleki P, Ding Y. Depressed renal and vascular nitric oxide synthase expression in cyclosporine‐induced hypertension. Kidney Int. 1998 ; 54: 482–91.
38. 38 Lopez‐Ongil S, Saura M, Rodriguez‐Puyol D, Rodriguez‐Puyol M, Lamas S. Regulation of endothelial NO synthase expression by cyclosporin A in bovine aortic endothelial cells. Am. J. Physiol. 1996 ; 271 (3 Pt 2): H1072–8.
39. 39 Karantzoulis‐Fegaras F, Antoniou H, Lai SL et al. Characterization of the human endothelial nitric‐oxide synthase promoter. J. Biol. Chem. 1999 ; 274: 3076–93.
40. 40 Yang WM, Inouye CJ, Seto E. Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity. J. Biol. Chem. 1995 ; 270: 15187–93.
41. 41 Basset el EA, Berthoux P, Cecillon S et al. Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, At1 R and ecNOS. Clin. Nephrol. 2002 ; 57: 192–200.